SEC Form 4 · accession 0001019687-15-002463
Ernexa Therapeutics Inc. · ERNA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Paul Yanover
Director
Period of report
Jun 19, 2015
Accepted (ET)
Jun 19, 2015 · 4:01 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000748592
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 19, 2015 | P | 7,900 | $0.2467 | A | 107,900 | I | See Footnote |
| Common StockF1 | Jun 19, 2015 | P | 32,100 | $0.2497 | A | 140,000 | I | See Footnote |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1By the Yanover/Prousky Family Trust